Innovative Research Focus Usona Institute specializes in pioneering clinical research on psilocybin and consciousness-expanding medicines, positioning it as a leader in groundbreaking mental health treatments that could transform therapeutic approaches for depression and anxiety.

Expanding Clinical Trials The organization is actively advancing to Phase 3 clinical trials, including collaborations with the University of New Mexico, indicating robust growth, increased research demand, and potential opportunities for partners in clinical development and trial support.

Recognition in Sustainability Receiving the AIA Wisconsin Special Recognition Award underscores Usona's commitment to sustainability, opening doors for partnerships focused on eco-friendly practices, sustainable medical research, and corporate social responsibility initiatives.

Funding and Revenue Growth With revenue estimates between 10 and 25 million dollars, Usona exhibits a solid financial foundation, presenting opportunities for funding collaborations, sponsorships, and investments aligned with innovative mental health solutions.

Partnership Opportunities Collaborations with academic institutions and other research organizations are evident, creating potential for business development efforts centered on joint research, clinical trial management, and expanding therapeutic applications of psilocybin.